3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年3月31日)
|
当連結会計年度
(2026年3月31日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
3,149,267
|
2,486,185
|
|
|
|
受取手形
|
34,326
|
32,405
|
|
|
|
売掛金
|
775,086
|
562,433
|
|
|
|
電子記録債権
|
177,201
|
87,578
|
|
|
|
商品及び製品
|
313,323
|
294,693
|
|
|
|
仕掛品
|
90,206
|
109,076
|
|
|
|
原材料及び貯蔵品
|
477,216
|
468,048
|
|
|
|
未収入金
|
13,757
|
15,868
|
|
|
|
その他
|
38,553
|
224,464
|
|
|
|
貸倒引当金
|
△1,975
|
△12,595
|
|
|
|
流動資産合計
|
5,066,964
|
4,268,157
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物
|
1,820,745
|
2,738,293
|
|
|
|
|
|
減価償却累計額
|
△748,904
|
△857,614
|
|
|
|
|
|
建物及び構築物(純額)
|
1,071,841
|
1,880,678
|
|
|
|
|
機械装置及び運搬具
|
1,010,676
|
1,077,962
|
|
|
|
|
|
減価償却累計額
|
△606,376
|
△737,446
|
|
|
|
|
|
機械装置及び運搬具(純額)
|
404,300
|
340,515
|
|
|
|
|
土地
|
599,172
|
849,099
|
|
|
|
|
リース資産
|
277,314
|
271,718
|
|
|
|
|
|
減価償却累計額
|
△60,722
|
△91,672
|
|
|
|
|
|
リース資産(純額)
|
216,592
|
180,046
|
|
|
|
|
建設仮勘定
|
747,036
|
321,587
|
|
|
|
|
その他
|
414,729
|
496,608
|
|
|
|
|
|
減価償却累計額
|
△200,020
|
△270,336
|
|
|
|
|
|
その他(純額)
|
214,709
|
226,272
|
|
|
|
|
有形固定資産合計
|
3,253,652
|
3,798,198
|
|
|
|
無形固定資産合計
|
27,262
|
18,927
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
投資有価証券
|
581,277
|
661,003
|
|
|
|
|
繰延税金資産
|
62,759
|
77,313
|
|
|
|
|
その他
|
74,731
|
80,796
|
|
|
|
|
投資その他の資産合計
|
718,768
|
819,112
|
|
|
|
固定資産合計
|
3,999,683
|
4,636,239
|
|
|
資産合計
|
9,066,648
|
8,904,397
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年3月31日)
|
当連結会計年度
(2026年3月31日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
支払手形及び買掛金
|
134,081
|
117,007
|
|
|
|
電子記録債務
|
75,344
|
66,678
|
|
|
|
短期借入金
|
1,500,000
|
1,500,000
|
|
|
|
1年内返済予定の長期借入金
|
150,000
|
150,000
|
|
|
|
リース債務
|
51,229
|
53,788
|
|
|
|
未払法人税等
|
114,136
|
21,195
|
|
|
|
賞与引当金
|
79,840
|
70,281
|
|
|
|
資産除去債務
|
-
|
11,560
|
|
|
|
その他
|
382,670
|
378,804
|
|
|
|
流動負債合計
|
2,487,303
|
2,369,315
|
|
|
固定負債
|
|
|
|
|
|
長期借入金
|
375,000
|
225,000
|
|
|
|
リース債務
|
310,307
|
262,721
|
|
|
|
退職給付に係る負債
|
46,000
|
46,995
|
|
|
|
資産除去債務
|
66,214
|
55,184
|
|
|
|
固定負債合計
|
797,522
|
589,901
|
|
|
負債合計
|
3,284,826
|
2,959,217
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
1,253,984
|
1,253,984
|
|
|
|
資本剰余金
|
1,153,134
|
1,153,134
|
|
|
|
利益剰余金
|
3,265,071
|
3,393,412
|
|
|
|
株主資本合計
|
5,672,189
|
5,800,530
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
3,427
|
3,906
|
|
|
|
為替換算調整勘定
|
106,204
|
140,742
|
|
|
|
その他の包括利益累計額合計
|
109,631
|
144,648
|
|
|
純資産合計
|
5,781,821
|
5,945,179
|
|
負債純資産合計
|
9,066,648
|
8,904,397
|
E38689
177A0
コージンバイオ株式会社
Kohjin Bio Co., Ltd.
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2025-04-01
2026-03-31
FY
2026-03-31
2024-04-01
2025-03-31
2025-03-31
1
false
false
false
177A0
2026-05-15
177A0
2025-04-01
2026-03-31
177A0
2025-04-01
2026-03-31
jppfs_cor:CapitalStockMember
177A0
2025-04-01
2026-03-31
jppfs_cor:CapitalSurplusMember
177A0
2025-04-01
2026-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
177A0
2025-04-01
2026-03-31
jpcrp_cor:ReconcilingItemsMember
177A0
2025-04-01
2026-03-31
jpcrp_cor:ReportableSegmentsMember
177A0
2025-04-01
2026-03-31
jppfs_cor:RetainedEarningsMember
177A0
2025-04-01
2026-03-31
jppfs_cor:ShareholdersEquityMember
177A0
2025-04-01
2026-03-31
tse-acedjpfr-177A0:CellProcessBusinessReportableSegmentMember
177A0
2025-04-01
2026-03-31
tse-acedjpfr-177A0:MicrobiologicalBusinessReportableSegmentMember
177A0
2025-04-01
2026-03-31
tse-acedjpfr-177A0:TissueCultureBusinessReportableSegmentMember
177A0
2025-04-01
2026-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
177A0
2025-04-01
2026-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
177A0
2026-03-31
177A0
2026-03-31
jppfs_cor:CapitalStockMember
177A0
2026-03-31
jppfs_cor:CapitalSurplusMember
177A0
2026-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
177A0
2026-03-31
jppfs_cor:RetainedEarningsMember
177A0
2026-03-31
jppfs_cor:ShareholdersEquityMember
177A0
2026-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
177A0
2026-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
177A0
2024-04-01
2025-03-31
177A0
2024-04-01
2025-03-31
jppfs_cor:CapitalStockMember
177A0
2024-04-01
2025-03-31
jppfs_cor:CapitalSurplusMember
177A0
2024-04-01
2025-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
177A0
2024-04-01
2025-03-31
jpcrp_cor:ReconcilingItemsMember
177A0
2024-04-01
2025-03-31
jpcrp_cor:ReportableSegmentsMember
177A0
2024-04-01
2025-03-31
jppfs_cor:RetainedEarningsMember
177A0
2024-04-01
2025-03-31
jppfs_cor:ShareholdersEquityMember
177A0
2024-04-01
2025-03-31
tse-acedjpfr-177A0:CellProcessBusinessReportableSegmentMember
177A0
2024-04-01
2025-03-31
tse-acedjpfr-177A0:MicrobiologicalBusinessReportableSegmentMember
177A0
2024-04-01
2025-03-31
tse-acedjpfr-177A0:TissueCultureBusinessReportableSegmentMember
177A0
2024-04-01
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
177A0
2024-04-01
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
177A0
2025-03-31
177A0
2025-03-31
jppfs_cor:CapitalStockMember
177A0
2025-03-31
jppfs_cor:CapitalSurplusMember
177A0
2025-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
177A0
2025-03-31
jppfs_cor:RetainedEarningsMember
177A0
2025-03-31
jppfs_cor:ShareholdersEquityMember
177A0
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
177A0
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
177A0
2024-03-31
177A0
2024-03-31
jppfs_cor:CapitalStockMember
177A0
2024-03-31
jppfs_cor:CapitalSurplusMember
177A0
2024-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
177A0
2024-03-31
jppfs_cor:RetainedEarningsMember
177A0
2024-03-31
jppfs_cor:ShareholdersEquityMember
177A0
2024-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
177A0
2024-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
iso4217:JPY
xbrli:pure